Pelabresib,Ruxolitinib
morphosys
['mpnsm', '#mpn']
congress| #eha2022 , reports on the safety/efficacy of pelabresib with rux in pts with mf from arms 2/3 in the manifest trial. results show splenic and symptom responses and bm fibrosis improvement plus good tolerability #mpn #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm